Literature DB >> 16769786

No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis.

P Härle, P Sarzi-Puttini, M Cutolo, R H Straub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16769786      PMCID： PMC1798194          DOI： 10.1136/ard.2005.040857

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Adipocytokines in synovial fluid.

Authors:  Andreas Schäffler; Angela Ehling; Elena Neumann; Hans Herfarth; Ingo Tarner; Jürgen Schölmerich; Ulf Müller-Ladner; Steffen Gay
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

2.  Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis.

Authors:  H J Anders; M Rihl; A Heufelder; O Loch; M Schattenkirchner
Journal:  Metabolism       Date:  1999-06       Impact factor: 8.694

3.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

4.  Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis.

Authors:  C Popa; M G Netea; T R D S Radstake; P L van Riel; P Barrera; J W M van der Meer
Journal:  Ann Rheum Dis       Date:  2005-02-24       Impact factor: 19.103

5.  Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status?

Authors:  F Perfetto; R Tarquini; G Simonini; G Bindi; F Mancuso; S Guiducci; M Matucci-Cerinic; F Falcini
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

6.  Tumor necrosis factor increases serum leptin levels in humans.

Authors:  M S Zumbach; M W Boehme; P Wahl; W Stremmel; R Ziegler; P P Nawroth
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

7.  Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.

Authors:  R H Straub; P Sarzi-Puttini; F Atzeni; F Buttgereit; M Carrabba; M Cutolo
Journal:  Ann Rheum Dis       Date:  2005-02-11       Impact factor: 19.103

8.  Leptin consumption in the inflamed joints of patients with rheumatoid arthritis.

Authors:  M Bokarewa; D Bokarew; O Hultgren; A Tarkowski
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

9.  Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies.

Authors:  Aurélie M Delaigle; Jean-Christophe Jonas; Isabelle B Bauche; Olivier Cornu; Sonia M Brichard
Journal:  Endocrinology       Date:  2004-08-19       Impact factor: 4.736

10.  Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.

Authors:  E Toussirot; N U Nguyen; G Dumoulin; F Aubin; J-P Cédoz; D Wendling
Journal:  Rheumatology (Oxford)       Date:  2004-10-05       Impact factor: 7.580
  10 in total
  26 in total

Review 1.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

Review 2.  [Adipocytokines as driving forces in rheumatoid arthritis].

Authors:  E Neumann; A Knedla; F Meier; I H Tarner; C Büchler; A Schäffler; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

3.  TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study.

Authors:  Éric Toussirot; Laurent Mourot; Barbara Dehecq; Daniel Wendling; Émilie Grandclément; Gilles Dumoulin
Journal:  Eur J Nutr       Date:  2013-10-31       Impact factor: 5.614

Review 4.  Roles of leptin in bone metabolism and bone diseases.

Authors:  Xu Xu Chen; Tianfu Yang
Journal:  J Bone Miner Metab       Date:  2015-03-18       Impact factor: 2.626

5.  Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum.

Authors:  L Senolt; D Housa; Z Vernerová; T Jirásek; R Svobodová; D Veigl; K Anderlová; U Müller-Ladner; K Pavelka; M Haluzík
Journal:  Ann Rheum Dis       Date:  2006-10-13       Impact factor: 19.103

Review 6.  Adipokines in bone disease.

Authors:  Elena Neumann; Susann Junker; Georg Schett; Klaus Frommer; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

Review 7.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.

Authors:  Inga-Lill Engvall; Birgitta Tengstrand; Kerstin Brismar; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2010-10-21       Impact factor: 5.156

9.  Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.

Authors:  Jon T Giles; Matthew Allison; Clifton O Bingham; William M Scott; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2009-09-15

10.  Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms.

Authors:  Ping Li; Li Yang; Cui-Li Ma; Bo Liu; Xin Zhang; Rui Ding; Li-qi Bi
Journal:  Clin Rheumatol       Date:  2015-03-10       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.